Sulfonylureas close these channels and restore insulin release, and have been successfully used to replace insulin treatment for patients with Kir6.2 mutations. Now, Hattersley et al. describe the ...
Am J Health Syst Pharm. 2006;63(10):929-938. The goal of sulfonylurea overdose management is the return of euglycemia, with either dextrose supplementation or reduction of insulin secretion.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback